[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340856-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340856-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","fstl3-is-associated-with-prognosis-and-immune-cell-infiltration-in-lung-adenocarcinoma","FSTL3 is associated with prognosis and immune cell infiltration in lung adenocarcinoma","","FSTL3 expression is altered across cancers, yet its function in lung adenocarcinoma development and tumor immunity remained unclear. The study assessed associations between FSTL3 levels and clinical features and immune-cell infiltration using lung adenocarcinoma data from TCGA plus a hospital validation cohort. Online analyses (GEPIA, GSEA, survival and immune-infiltration correlations) and validation immunohistochemistry evaluated prognosis, staging, and tumor-infiltrating immune cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/fstl3-is-associated-with-prognosis-and-immune-cell-infiltration-in-lung-adenocarcinoma/340856/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/fstl3-is-associated-with-prognosis-and-immune-cell-infiltration-in-lung-adenocarcinoma/340856.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main purpose of this study on FSTL3 in lung adenocarcinoma?","Question",{"text":63,"@type":64},"To determine how FSTL3 expression relates to clinical characteristics, tumor immunity, and immune-cell infiltration in lung adenocarcinoma using TCGA data and a validation set.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers evaluate the relationship between FSTL3 and prognosis?",{"text":68,"@type":64},"They analyzed correlations between FSTL3 expression and prognosis, clinical stage, survival status, and tumor-infiltrating immune cells using online tools such as GEPIA, and they performed immunohistochemistry in a validation dataset.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding immune-cell infiltration and biological pathways?",{"text":72,"@type":64},"FSTL3 expression was reduced in lung adenocarcinoma, correlated with N stage, pathological stage, and overall survival, and was linked to immune levels of B cells, T cells, NK cells, and neutrophils as well as pathways including DNA replication and cell-cycle regulation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340856,1790176315,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Journal of Cancer Research and Clinical Oncology (2024) 150:17  \n[https://doi.org/10.1007/s00432-023-05553-w](https://doi.org/10.1007/s00432-023-05553-w)  \nFSTL3 is associated with prognosis and immune cell infiltration in lung adenocarcinoma  \nXiangzhi Meng1 · Xiaojian Zhao1 · Boxuan Zhou1 · Weijian Song1 · Yicheng Liang2 · Mei Liang1 · Minjun Du1 · Jianwei Shi1 · Yushun Gao1  \nReceived: 2 November 2023 / Accepted: 15 November 2023 / Published online: 19 January 2024 © The Author(s) 2024  \nAbstract  \nPurpose FSTL3 expression is altered in various types of cancer. However, the role and mechanism of action ofFSTL3 in lung adenocarcinoma development and tumor immunity are unknown. We investigated the association between FSTL3 expression and clinical characteristics and immune cell infiltration in lung adenocarcinoma samples from The Cancer Genome Atlas (TCGA) and a separate validation set from our hospital.  \nMethods Data on immune system infiltration, gene expression, and relevant clinical information were obtained by analyzing lung adenocarcinoma sample data from TCGA database. Using online tools like GEPIA, the correlations between FSTL3 expression and prognosis, clinical stage, survival status, and tumor-infiltrating immune cells were examined. In a validation dataset, immunohistochemistry was performed to analyze FSTL3 expression and its related clinical characteristics.  \nResults FSTL3 expression was markedly reduced in patients with lung adenocarcinoma. N stage, pathological stage, and overall survival were significantly correlated with FSTL3 expression. According to GSEA, FSTL3 is strongly linked to signaling pathways such as DNA replication and those involved in cell cycle regulation. Examination of TCGA database and TIMER online revealed a correlation between FSTL3 and B cell, T cell, NK cell, and neutrophil levels. The prognosis of patients with lung adenocarcinoma was significantly affected by six genes (KRT6A, VEGFC, KRT14, KRT17, SNORA12, and KRT81) related to FSTL3 .  \nConclusion FSTL3 is significantly associated with the prognosis and progression of lung adenocarcinoma and the infiltration of immune cells. Thus, targeting FSTL3 and its associated genes in immunotherapy could be potentially beneficial for the treatment of lung adenocarcinoma.  \nKeywords FSTL3 · Lung adenocarcinoma · Prognosis · Immune cell infiltration  \nXiangzhi Meng and Xiaojian Zhao have contributed equally to this work.  \n* Yushun Gao [ysgaopumc@163.com](ysgaopumc@163.com)  \n1 Department of Thoracic Surgery, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing 100021, People’s Republic of China  \n2 Department of Thoracic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 107 Yanjiang West Road, Guangzhou 510120, China  \nIntroduction  \nLung cancer is a highly prevalent and deadly form of malignant tumor (Bray et al. 2018) . Non-small cell lung cancer (NSCLC), which comprises approximately 80–85% of all lung cancer cases, can be further categorized into two main subtypes: lung adenocarcinoma (LUAD) and lung squamous cell carcinoma. LUAD accounts for approximately 40% of all lung cancers and is the most prevalent form of lung cancer. Despite the development of treatments to enhance patient outcomes, prognosis remains unfavorable for patients with LUAD. The 5-year survival rate of patients with advanced cancer is 10–15%(Kim et al. 2020 ; Siegelet al. 2012). Currently, surgery, radiotherapy, chemotherapy, and targeted therapy are the primary therapeutic approaches for LUAD. However, these methods insufficiently improve  \nFig. 1 Comparison of the expression of FSTL3 in normal and LUAD tumor tissues. Analysis of FSTL3 expression in normal and LUAD tissues was conducted using paired (A) and unpaired (B) methods. Additionally, Kaplan–Meier survival curve analysis was performed to examine th","cbCaiizFuBvOXbXm","https://ap.wps.com/l/cbCaiizFuBvOXbXm","pdf",11770712,15,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Methods and Analyses","[{\"question\":\"What was the main purpose of this study on FSTL3 in lung adenocarcinoma?\",\"answer\":\"To determine how FSTL3 expression relates to clinical characteristics, tumor immunity, and immune-cell infiltration in lung adenocarcinoma using TCGA data and a validation set.\"},{\"question\":\"How did the researchers evaluate the relationship between FSTL3 and prognosis?\",\"answer\":\"They analyzed correlations between FSTL3 expression and prognosis, clinical stage, survival status, and tumor-infiltrating immune cells using online tools such as GEPIA, and they performed immunohistochemistry in a validation dataset.\"},{\"question\":\"What were the key findings regarding immune-cell infiltration and biological pathways?\",\"answer\":\"FSTL3 expression was reduced in lung adenocarcinoma, correlated with N stage, pathological stage, and overall survival, and was linked to immune levels of B cells, T cells, NK cells, and neutrophils as well as pathways including DNA replication and cell-cycle regulation.\"}]","FSTL3 is associated with prognosis and immune cell infiltration in lung adenocarcinoma | PDF",1790039188,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa74d33e9f177be395a69b605ee3129a.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/680c3ea666cc7be5d21284f46b28309d.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec8f5d2c7bf758cf64c388cc1568eb81.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c2a27fc353b40b242b80f038af6cd82.webp",980,1301]